Retningslinjer for screening og profylakse før behandling med biologiske lægemidler (2023)
Omhandler biologiske og målrettede syntetiske lægemidler (BMSL) til patienter i forhold til risiko for tuberkulose (TB), Humant Papillom Virus (HPV), Hepatitis B og C (HBV og HCV), Varicella Zoster Virus (VZV), Herpes Simplex Virus (HSV), Cytomegalovirus (CMV), Epstein Barr Virus (EBV) og Humant Immundefekt Virus (HIV) og øvrige infektioner.
Vejledningen er udarbejdet af repræsentanter fra Dansk Selskab for Gastroenterologi og Hepatologi (DSGH), Dansk Reumatologisk Selskab (DRS), Dansk Dermatologisk Selskab (DDS) og Dansk Selskab for Infektionsmedicin (DSI).
961 KB, Uploadet 9. januar 2024
2
Tuberkulose - diagnostik og behandling (2023)
Denne vejledning omhandler diagnostik og behandling af voksne med TB, herunder pulmonal- og ekstrapulmonal-TB samt antibiotika-resistent TB.
For håndtering af infektioner forårsaget af andre mykobakterier henvises til anden litteratur.
26.09.23: Moxifloxacin varighed ændret til 8 uger (tabel 10)
630 KB, Uploadet 26. september 2023
3
Tuberkuloseinfektion hos immunsupprimerede (2023)
Denne vejledning omhandler vurdering og behandling af tuberkuloseinfektion hos voksne, som skal behandles med immunsupprimerende medicin i form af f.eks TNF-α hæmmere eller andre immunsupprimerende biologiske lægemidler, hvor der er øget risiko for tuberkulosereaktivering.
Guideline dækker ikke børn, personer med medfødt immundefekt, HIV positive, patienter i dialyse, patienter med dysreguleret diabetes, silicose, erhvervede immundefekter eller patienter i konventionel kortvarig kemoterapi.
Denne guideline omhandler ikke klassisk smitteopsporing blandt tuberkuloseeksponerede eller udredning på mistanke om aktiv tuberkulose.
472 KB, Uploadet 26. februar 2023
4
Vaccination af voksne kandidater og recipienter til solid organtransplantation (2022)
Udarbejdet af en arbejdsgrupper bestående af medlemmer fra Dansk Selskab for Infektionsmedicin og Dansk Transplantationsselskab
600 KB, Uploadet 24. april 2022
5
Tuberkuloseskema (2015)
Skema til registerering af diagnostik, behandling og respons
Survival and factors associated with mortality among people with tuberculosis in Medellin, Colombia (2018-2023): a retrospective cohort study
BMJ Open
Tilføjet 3. december 2025
2
Factors influencing drug-susceptible tuberculosis treatment outcomes in Romania and Ukraine
PLoS One Infectious Diseases
Tilføjet 3. december 2025
3
Correction: Activation and proliferation profiles of M.tuberculosis specific dual functional CD4+T cells from smear negative pulmonary TB patients
PLoS One Infectious Diseases
Tilføjet 2. december 2025
4
Reply to Liao et al.: Optimizing Levofloxacin Dosing for Multidrug-resistant Tuberculosis in Low–Fat-Free Mass Asian Populations
American Journal of Respiratory and Critical Care Medicine
Tilføjet 2. december 2025
5
Optimizing Levofloxacin Dosing for Multidrug-resistant Tuberculosis in Low–Fat-Free Mass Asian Populations
American Journal of Respiratory and Critical Care Medicine
Tilføjet 1. december 2025
6
Impact of drug-resistance diagnosis based on whole-genome sequencing on the treatment adequacy of patients with drug-resistant pulmonary tuberculosis in the state of Sao Paulo, Brazil: a protocol for a non-randomised controlled trial (Gen-TB ProCura)
BMJ Open
Tilføjet 30. november 2025
7
Person-centred care for people with tuberculosis-associated comorbidities: a multi-country qualitative study
BMJ Open
Tilføjet 29. november 2025
8
Association between latent tuberculosis infection and assisted reproductive outcomes: a systematic review and meta-analysis
BMJ Open
Tilføjet 28. november 2025
9
Diagnostic Yield of urine Xpert MTB/RIF Ultra to detect Mycobacterium tuberculosis among severely immunosuppressed inpatients with HIV: a prospective cohort study in Ghana
International Journal of Infectious Diseases
Tilføjet 29. november 2025
10
Type I interferons in tuberculosis pathogenesis and prevention
Trends in Microbiology
Tilføjet 29. november 2025
11
Incidence and predictors of mortality among TB-HIV co-infected individuals on anti-tuberculosis and anti-retroviral dual therapy in Northwest Ethiopia: A retrospective cohort study
PLoS One Infectious Diseases
Tilføjet 27. november 2025
12
Intestinal Talaromyces marneffei infection masquerading as tuberculosis and crohn's disease
International Journal of Infectious Diseases
Tilføjet 27. november 2025
13
Correction: Epidemiological factors associated with immunological resistance in household contacts exposed to active tuberculosis in South Africa: A logistic regression analysis
PLoS One Infectious Diseases
Tilføjet 26. november 2025
14
Diagnostic Accuracy of Lung Ultrasound for Pulmonary Tuberculosis in out-patients from Papua New Guinea, a Resource-Limited setting
International Journal of Infectious Diseases
Tilføjet 24. november 2025
15
A 6 to 9-month oral regimen for rifampicin-resistant tuberculosis: a randomised open-label non-inferiority trial in China
Clinical Microbiology and Infection
Tilføjet 24. november 2025
16
Tuberculosis Among Shanghai’s Homeless: A Retrospective Cohort Study Highlighting Critical Care Gaps
International Journal of Infectious Diseases
Tilføjet 23. november 2025
17
Effect of first visit to different levels of medical institutions on diagnostic and treatment delays in pulmonary tuberculosis in Ningxia, China: a cross-sectional study from 2015 to 2019
BMJ Open
Tilføjet 22. november 2025
18
Integration of Tobacco-Cessation Interventions into Tuberculosis and HIV Care
New England Journal of Medicine
Tilføjet 17. november 2025
19
Diagnostic Accuracy of a Novel Point-of-Care Tongue Swab Assay for Pulmonary Tuberculosis: A Multicenter Prospective Study
Clinical Microbiology and Infection
Tilføjet 17. november 2025
20
Model-Informed Evidence for Rifapentine Use in Chinese HIV-Positive Adults with Latent Tuberculosis: Assessing Ethnic PK Differences and Interactions with Ritonavir